About

Jeffrey R. Stewart is AbbVie's Executive Vice President, Chief Commercial Officer. He previously served as Senior Vice President, U.S. Commercial Operations and as President, U.S. Commercial Operations, and before AbbVie's separation from Abbott was Vice President of Abbott's Proprietary Pharmaceutical Division, United States. Mr. Stewart joined Abbott in 1992 and was first appointed as an AbbVie corporate officer in December 2018.

Roles

AbbVie Inc.
Executive Vice President, Chief Commercial Officer · Current role
Dec 2018–present
AbbVie
Senior Vice President, U.S. Commercial Operations
2018 - 2020
AbbVie
President, U.S. Commercial Operations
2013 - 2018
Abbott
Vice President, Proprietary Pharmaceutical Division, United States · Joined Abbott in 1992

Fixed Compensation

FY 2025
Base Salary
$1,315,726
Change in Pension Value & Nonqualified Deferred Compensation Earnings
$3,742,237
All Other Compensation
$737,376

Performance Compensation

Data from FY 2025

Cash incentive

Annual Cash Incentive (Non-Equity Incentive Plan Compensation)
$2,950,000
Target Opportunity
ProgramAbbVie annual cash incentive plan

Stock awards

Stock Awards (grant-date fair value)
$5,390,310
VehiclesPerformance shares (EPS + relative TSR, 0-250% of target) and performance-vested RSUs (relative ROIC, 0-200% of target)
2025 resultAdjusted diluted EPS performance banked the 2025 performance-share award at 200% of target (TSR-modified vesting through Dec 31, 2027); relative ROIC vested one-third of the PVRSU award at 200% of target
Option Awards (grant-date fair value)
$1,299,655
VestingOne-third after each of years one, two and three of service

Also at AbbVie Inc.

Related

See how VectorShift works for your firm

Request Demo